Cargando cotizaciones...
Previsión
No hay datos de analistas disponibles para esta empresa.
Noticias Ir al feed de noticias
Animalcare Group delisted from AIM after takeover by Charterhouse subsidiary
The shares of Animalcare Group were removed from trading on the AIM of the London Stock Exchange on Wednesday morning after CCP PAW 2 Limited — a 100% subsidiary of funds managed/advised by Charterhouse Capital Partners — acquired the company via a scheme of arrangement under Part 26 of the Companies Act 2006. The scheme took effect on Wednesday; Animalcare plans to convert into a private limited company. Financial and legal advisers on the transaction included Rothschild & Co, Stifel Nicolaus Europe, Panmure Liberum, Allen & Overy and Squire Patton Boggs. » Más en de.investing.com
Animalcare Group issues 967,954 new shares after option exercise
Following court approval of the takeover scheme and the exercise of outstanding options, Animalcare Group has issued 967,954 new ordinary shares. The exercise followed the takeover announcement by CCP PAW 2 Limited (Charterhouse) and rendered the options vested and exercisable under Rule 15 of the Takeover Code. The new shares are expected to be admitted to trading on AIM on Tuesday at around 08:00; issued share capital rises to 70,013,899 shares of 20 pence each. CEO Jennifer Winter received 468,797 shares (total 569,447; 0.81%) and CFO Christopher Brewster 188,384 shares (total 473,897; 0.68%). » Más en de.investing.com
JPMorgan increases stake in Animalcare Group to 6.356%
JPMorgan Chase & Co. has increased its voting stake in the Animalcare Group to 6.356% and now holds 4,388,686 voting rights. The position comprises 6.351% direct share voting rights via J.P. Morgan Securities PLC and 0.005% through cash-settled equity swaps with maturities to November 2026 and July 2027. The notification was made in accordance with UK disclosure requirements. » Más en de.investing.com
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasDatos financieros de la empresa
| (EUR) | diciembre de 2025 | YoY |
|---|---|---|
| Ingresos | 51,98 M | - |
| Beneficio bruto | 25,51 M | - |
| Beneficio neto | 2,08 M | - |
| EBITDA | 9,3 M | - |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 277,3 M € |
Número de acciones | 69,05 M |
Máximo/mínimo de 52 semanas | 4,08 € - 2,59 € |
Rentabilidad por dividendo | 0,64 % |
Dividendos TTM | 0,0249 € |
Beta | 0,67 |
Ratio P/E | 45,39 |
Ratio PEG | -0,53 |
Ratio P/B | 2,02 |
Ratio P/S | 2,60 |
Perfil de la empresa
Animalcare Group plc se dedica al desarrollo, la venta y la distribución de productos farmacéuticos veterinarios con licencia y de productos de identificación, así como de servicios para animales de compañía, animales de producción y el mercado veterinario equino. También participa en la venta al por mayor y la comercialización de productos farmacéuticos veterinarios. La empresa atiende a clientes en Bélgica, los Países Bajos, el Reino Unido, Alemania, España, Italia, Portugal, otros países europeos, Asia, Oriente Medio, África e internacionalmente. Animalcare Group plc fue constituida en 1972 y tiene su sede en York, Reino Unido.
| Nombre | ANIMALCARE GROUP |
| CEO | Jennifer Ann Julia Winter |
| Sede | York,
ny Reino Unido |
| Sitio web | |
| Salida a bolsa | 15/01/2008 |
| Empleados | 220 |
Deep Dive
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
London Stock Exchange | ANCR.L |
London | ANCR.L |